Navigation Links
Aethlon Medical to Discuss Recent Progress at the LHA Life Sciences & Medical Technologies Virtual Conference on June 16
Date:6/7/2011

SAN DIEGO, June 7, 2011 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will provide a company overview, discuss recent developments and review upcoming milestones at the 5th LHA Life Sciences & Medical Technologies Virtual Conference.  

(Photo:  http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)

The webcast presentation will be available Thursday, June 16, 2011, at 10:00 a.m. Pacific time (1:00 p.m. Eastern time) by visiting the Company's website at: www.aethlonmedical.com

Aethlon further disclosed that Company President Rodney S. Kenley will discuss the role of the Aethlon Hemopurifier® in the treatment of hepatitis C virus (HCV) in a presentation tomorrow at the 20th International Vicenza Course of Hemodialysis and CKD in Vicenza, Italy.  The Aethlon Hemopurifier® is first-in-class therapeutic filtration device that selectively removes infectious viruses and immunosuppressive toxins from the entire circulatory system through the use of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide. Mr. Kenley's presentation, "The Treatment of HCV with Affinity Plasmapheresis on Dialysis Machines," will focus on treating HCV in existing dialysis clinics with no change in infrastructure or capital investments.  The Hemopurifier® can be used to treat HCV in dialysis patients, in whom the prevalence of HCV is over 100 times higher than the general population, as well as non-dialysis patients.  Access to Mr. Kenley's slide presentation will be provided on the Aethlon Medical website after the conclusion of the event.

About Aethlon Medical

The Aethlon Medical mission
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
2. Aethlon Medical Clarifies News Report
3. ABC News Reports on Aethlon Medical
4. Aethlon Medical Announces Multi-Target Exosome Assay Validation
5. Aethlon Medical Releases Shareholder Letter
6. Aethlon Medical Receives FDA Approval to Export its Hemopurifier® to India
7. Aethlon Medical Releases Shareholder Letter
8. Aethlon Medical to Host Investor Event on January 20, 2011
9. Aethlon Medical Announces Presentation at U.S. Department of Health and Human Services BARDA Industry Day
10. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
11. Aethlon Medical to Present at the Singular Research Fifth Annual Best of the Uncovereds Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Reportlinker.com announces that a new ... catalogue: PharmaPoint: Atopic ... Analysis to 2022 http://www.reportlinker.com/p01957657/PharmaPoint-Atopic-Dermatitis---India-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... India Drug Forecast and Market Analysis to ...
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly ... and painless for patients to self-inject prescription drugs in the ... including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... grow to $220B by 2018, according to analysts.   Many of ...
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, Inc. ... today that it acquired Progressive Home Medical Equipment, Inc. ("Progressive") ... 2014. The terms of the acquisition were not disclosed. ... ("DME") company providing a wide range of sleep, mobility, and ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... MINNEAPOLIS , Feb. 4 ATS Medical, Inc. (Nasdaq: ... today announced that it will release financial results for the fourth quarter ... Monday, March 1, 2010 .  The Company will host a conference call ... p.m. Eastern Time ( 2:00 p.m. Pacific Time ) to discuss ...
... , FREMONT, Calif. , ... Limited (Nasdaq: INFY ) today announced that it will design ... (NYSE: ELN ), a leading biotechnology company, to accelerate ... existing intellectual property in this field. , "We are confident ...
Cached Medicine Technology:ATS Medical Announces Fourth Quarter 2009 Earnings Release Date and Conference Call 2ATS Medical Announces Fourth Quarter 2009 Earnings Release Date and Conference Call 3Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research 2Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research 3Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research 4
(Date:4/17/2014)... Canadians surveyed said they would participate in public health ... genetic conditions, only 80 per cent said they would ... their newborns, genomes.,Most newborns in North America have a ... of life in which a tiny amount of blood ... five to 54 conditions, depending on the state or ...
(Date:4/17/2014)... An anti-malarial treatment that lost its status as the ... a new lease of life, with new research indicating ... findings could revive the use of the cheap anti-malarial ... which claims the lives of more than half a ... parasite that causes malaria has developed resistance to chloroquine, ...
(Date:4/16/2014)... The Translational Genomics Research Institute (TGen) recently honored two ... their support of TGen,s research into brain, colon and ... Scottsdale. , Catherine Ivy, Founder and President of The ... McCain Leadership Award, named for U.S. Sen. John McCain ...
(Date:4/16/2014)... DOWNERS GROVE, Ill. April 16, 2014 According ... surveillance colonoscopy in average-risk patients with one to two ... 90 percent of cases. This may be an appropriate ... endoscopic database study to quantify adherence to guidelines for ...
(Date:4/15/2014)... fish caused nearly half of all injuries aboard commercial ... freezer-longliner vessels operating off the coast of Alaska, new ... those injuries and others aboard the two types of ... the research methods used in the study could help ...
Breaking Medicine News(10 mins):Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:Scientists find new way to fight malaria drug resistance 2Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 2Health News:Surveillance colonoscopy recommendations for average-risk patients with 1 to 2 small polyps consistent with guidelines 3Health News:Changes in processing, handling could reduce commercial fishing injuries 2
... , PLYMOUTH MEETING, Pa., Nov. 16 In this ... are scrutinizing costs and being forced to make tough decisions affecting ... technologies clamoring for attention, knowing which ones to focus on can ... asked by health plans around the country, ECRI Institute(R) ( ...
... 16 With health care reform taking the national ... that some form of change is necessary. Many health care ... government-mandated change because innovation has already begun to occur organically ... defining that innovation and garnering attention in the industry. , ...
... Other Requests: Harmonize Regulations and Avoid Duplicate Fees ... products pose a significant food safety hazard, facilities producing these ... regulations proposed so far this year by Congress. These facilities ... which are know as the Pasteurized Milk Ordinance (PMO), that ...
... But risk is highest for women with aura, researchers find ... migraines have more than double the risk of ischemic stroke, ... study has found. , Ischemic stroke, the most common type ... cut off by plaque accumulation or a blood clot. , ...
... As many software companies work to create programs that ... are reported, a new study by researchers at Wake Forest ... not improve, but rather decreases the completeness and accuracy of ... Radiology , compared the accuracy and completeness of reporting test ...
... 2009Although women have made strides in the business world, ... leadership positions in the Fortune 500. Not surprisingly therefore ... and most industries are considered to be male-typed at ... positions within a handful of industries, these industries are ...
Cached Medicine News:Health News:ECRI Institute Issues Health Plan Watch List: 2010 Top 7 Technologies; Exclusive Insights in White Paper, Available for Free Download 2Health News:ECRI Institute Issues Health Plan Watch List: 2010 Top 7 Technologies; Exclusive Insights in White Paper, Available for Free Download 3Health News:Health Care Robots: Next Generation Decision-Making Software, Eliminates Manual Systems Labor 2Health News:Health Care Robots: Next Generation Decision-Making Software, Eliminates Manual Systems Labor 3Health News:Dairy Groups Urge Senators to Include Raw Milk Facilities in Food Safety Regulations 2Health News:Dairy Groups Urge Senators to Include Raw Milk Facilities in Food Safety Regulations 3Health News:Migraine Increases Likelihood of Stroke 2Health News:Structured reporting software creates less complete and accurate radiology reports than free text 2Health News:Structured reporting software creates less complete and accurate radiology reports than free text 3
The PHOS method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of phosphorus in serum....
For the quantitative in vitro determination of total and direct bilirubin in serum or plasma....
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
For the quantitative in vitro determination of IgA in serum and plasma. This product is suitable for use on Hitachi 704, 705, 717, 902, 911 and 912....
Medicine Products: